Recurrent miscarriage is the loss of two or more pregnancies documented by ultrasound or clinical exam—a definition now used by the American Society for Reproductive Medicine to identify women who need investigation. Between 1 and 3 percent of women experience recurrent pregnancy loss, compared to 30 percent who lose a single pregnancy at some point in life, making it far less common than isolated loss but common enough that doctors have developed a systematic approach to find answers.
An investigation for recurrent miscarriage follows a clear sequence: testing tissue from a loss when possible, checking your chromosomes and your partner's, imaging your uterus, and selective testing for blood-clotting problems. Many causes are treatable or manageable, and even when investigation finds no clear reason, about 75 percent of women achieve a successful next pregnancy without medical intervention. Understanding what doctors look for, why, and what the results mean is the first step toward moving forward.
Table of Contents
- What Recurrent Miscarriage Is and How Common It Is
- Chromosomal Abnormalities—The Most Common Cause
- Parental Chromosome Rearrangements—A Less Common Inherited Risk
- Antiphospholipid Syndrome—The Only Proven Clotting Cause
- Structural Problems Inside the Uterus
- The Diagnostic Workup—What Gets Tested and Why
- When Investigation Finds Nothing
- Age, Egg Quality, and Why Outcomes Are Still Favorable
- Choosing Your Healthcare Team and Preparing for Investigation
- Moving Forward After Investigation and Next Pregnancy Planning
- Frequently Asked Questions
What Recurrent Miscarriage Is and How Common It Is
Recurrent pregnancy loss, commonly called recurrent miscarriage, begins at two losses—not three or more, which was the older standard. The American Society for Reproductive Medicine now recommends investigating after two documented losses because earlier intervention can identify treatable conditions and reduce further loss. A clinical pregnancy loss means a loss confirmed by ultrasound or tissue examination, not a biochemical pregnancy (a positive test that fails before an ultrasound can show a sac).
The pregnancies do not need to be with the same partner, and they can occur naturally or after fertility treatment. Some women lose pregnancies in the first weeks; others carry further before loss. The pattern may differ each time—one loss at 10 weeks, the next at 6 weeks—because the underlying causes vary from loss to loss.
Approximately 1 to 3 percent of women experience recurrent loss, according to the National Center for Biotechnology Information. This is substantially less common than a single miscarriage, which happens to about 30 percent of people at some point. Having one loss does not predict a second; most women who lose one pregnancy go on to have healthy pregnancies.
The distinction from unexplained single loss matters because it opens investigation. After one loss, doctors generally offer reassurance. After two, most will order systematic testing. Knowing this definition helps you recognize when your experience fits the pattern that prompts action, and when talking with your doctor, it ensures you are discussing the same criteria.
Chromosomal Abnormalities—The Most Common Cause
Chromosomal errors are the leading cause of both early miscarriage and recurrent loss. Embryonic chromosomal abnormalities (called aneuploidy when there are extra or missing chromosomes) account for approximately 50 to 60 percent of all early spontaneous miscarriages and 30 to 57 percent of recurrent losses. They are the reason many miscarriages happen before eight weeks—the pregnancy simply cannot develop with an unbalanced set of chromosomes.
These errors happen randomly during the formation of eggs or sperm. During meiosis—the cell division that creates reproductive cells—chromosomes occasionally distribute unevenly, producing an egg or sperm with an extra copy of a chromosome (like trisomy 21) or a missing piece. When that cell fertilizes or is fertilized, the resulting embryo inherits the error.
There is nothing a parent did to cause it, and it is not preventable—it is a chance event. Chromosomal errors become more common with advancing maternal age, particularly after age 35. A woman's eggs are present from birth and decline in quality over decades; the longer an egg waits to ovulate, the higher the risk of a division error during meiosis.
This is why age is one factor that influences recurrent loss risk, though young women also experience chromosomal errors. The same random process that caused one loss can cause another, independent of the first. If two losses were both trisomy 21, for example, that was coincidence—both were random errors, not an inherited pattern. Testing tissue from a loss (using microarray, a genetic test) can reveal which chromosome was affected, providing information that helps guide further investigation.
Because chromosomal errors are random, not inherited, a woman with recurrent chromosomal losses does not necessarily carry a chromosome abnormality herself. Her chromosomes can be completely normal. The problem is not her genetic makeup; it is the luck of egg or sperm formation in this particular series of pregnancies. This is an important distinction because it means some couples can move forward with next pregnancy after confirming neither partner carries a rearrangement.
Parental Chromosome Rearrangements—A Less Common Inherited Risk
In 3 to 5 percent of couples with recurrent miscarriage, one partner carries a balanced chromosomal translocation. This means one of their chromosomes has rearranged—a piece has moved from one chromosome to another—but no genetic material is actually missing. The parent usually has no symptoms and no health effects because they have all the genetic information they need.
However, when that parent's reproductive cells divide, the rearrangement can distribute unevenly. A partner carrying a balanced translocation passes unbalanced chromosomes to an embryo in roughly 10 to 15 percent of pregnancies, creating an embryo with missing or extra genetic material. These unbalanced embryos cannot develop and are lost, often early.
If chromosomal testing of tissue from a loss shows an unbalanced abnormality, the next step is usually karyotype testing (a full chromosome count) of both parents. Karyotyping is a blood test that reveals the structure and number of a parent's chromosomes. If one parent is found to carry a balanced translocation, that explains the pattern of loss—the carrier parent is shedding chromosomally unbalanced pregnancies at random.
Knowing one partner carries a balanced translocation affects reproductive choices. Some couples choose to use preimplantation genetic testing (PGT) with in vitro fertilization to select unaffected embryos for transfer. Others accept a higher loss rate and attempt natural pregnancy, which still has favorable odds—many carriers have successful pregnancies despite the higher risk.
Genetic counseling is recommended when a translocation is found. A counselor can discuss how the translocation was inherited, whether other relatives should be tested, and what options exist for future pregnancies. This is a time to discuss not just medical options but personal and ethical values.
Antiphospholipid Syndrome—The Only Proven Clotting Cause
Antiphospholipid syndrome, or APS, is the only blood-clotting disorder with established, proven causation for recurrent pregnancy loss. APS is an autoimmune condition in which the body produces antibodies against proteins involved in blood clotting. In pregnancy, APS promotes clotting in the placenta, restricting blood flow to the developing pregnancy and leading to loss, often in the second or third trimester.
APS antibodies are present in 5 to 15 percent of women with recurrent miscarriage, compared to 2 to 5 percent of unselected pregnant women. This means APS is more common in people with recurrent loss, but it still accounts for only a portion of cases. The diagnosis requires two separate positive antibody tests at least 12 weeks apart because a single positive can be transient and not indicate true APS.
Diagnosis involves blood testing for three specific markers: lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein antibodies. A positive test on just one or both initial tests is not enough; the positivity must be confirmed after 12 weeks. This waiting period is frustrating when you want answers quickly, but it prevents false positives. If APS is confirmed, treatment is straightforward and highly effective.
Low-dose aspirin begun before conception, combined with low-molecular-weight heparin (an injectable blood thinner) after pregnancy is confirmed, dramatically improves pregnancy success rates. Most women with APS-related losses who receive treatment go on to have successful pregnancies. Other inherited thrombophilias—like factor V Leiden, prothrombin mutation, and homozygous MTHFR variants—were once thought to cause recurrent loss, but current research does not support a causal link between these conditions and recurrent pregnancy loss. Testing for these is not routinely recommended, though some doctors still order it.
Structural Problems Inside the Uterus
The shape and structure of the uterus matter for pregnancy. Several structural abnormalities can contribute to recurrent loss or difficulty maintaining pregnancy: a uterine septum (a wall dividing the uterine cavity), polyps (benign growths), fibroids (benign muscle tumors), scarring from prior surgery or infection, and intrauterine adhesions (scar tissue joining opposite walls). A septate uterus—where a fibrous wall partially or completely divides the cavity—reduces the blood supply to one side, making it harder for a pregnancy to implant and grow normally on that side.
Because half the uterus has poor blood supply, a pregnancy there is at higher risk of loss. This is correctable with a minimally invasive surgery called hysteroscopic septum resection, where the dividing wall is removed through the cervix. Polyps and fibroids, depending on their size and location, can interfere with implantation or pregnancy growth. A fibroid pressing into the uterine cavity reduces available space; a large polyp occupying the cavity where an embryo needs to implant increases loss risk.
Smaller fibroids away from the cavity usually do not affect pregnancy, and removal is not always recommended. Scarring from dilation and curettage (D&C) during previous losses, from abortion care, or from infection can damage the uterine lining, reducing the blood supply available to a pregnancy. Severe scarring, called Asherman syndrome, can prevent successful pregnancy until adhesions are removed.
Milder scarring may not prevent pregnancy but can increase loss risk. Structural problems are found by imaging: transvaginal ultrasound (an ultrasound probe inside the vagina) can visualize the cavity shape; hysterosalpingography (HSG), where dye is injected into the uterus and filmed on X-ray, outlines the cavity and tubes; or hysteroscopy (placing a small camera inside the uterus) directly visualizes the cavity. If an abnormality is found and thought to be contributing to loss, surgery can often correct it.
The Diagnostic Workup—What Gets Tested and Why
Current guidelines from ACOG and ASRM recommend a specific sequence of investigation after recurrent loss. The process begins with chromosome testing of miscarriage tissue when tissue is available. This is the single most important test because it identifies whether each loss was chromosomally abnormal, pointing toward either random error or parental chromosome problems.
Tissue testing uses microarray, a genetic test that detects missing or extra chromosome segments. If tissue shows chromosomal abnormality, parental karyotyping comes next to determine if a parent carries a balanced rearrangement. If tissue is normal, or if tissue is unavailable, parental karyotyping may still be done based on your doctor's judgment. Uterine imaging is routine in the workup.
Transvaginal ultrasound is often first because it is non-invasive and effective. If the shape is unclear or abnormality is suspected, HSG (hysterosalpingography) or hysteroscopy provides more detail. These tests reveal septum, polyps, fibroids, scarring, or other structural issues. The choice of test depends on what your doctor suspects and your preference. Antiphospholipid antibody testing is conditional—recommended if you have specific risk factors.
These include a loss in the second or third trimester, multiple early losses with no chromosomal abnormality detected, a family history of blood clots or autoimmune disease, or a personal history of blood clots. If no risk factors apply, APS testing may be skipped initially. Additional tests are sometimes considered: tests for thyroid disease, vitamin deficiencies, or uterine blood flow.
However, the standard guideline-recommended workup focuses on the tests above because evidence strongest supports their role in recurrent loss. Your doctor may recommend other tests based on your individual history. The testing process takes time. Getting tissue for chromosomal testing requires scheduling after a loss and passing tissue for analysis (often weeks).
Parental karyotyping takes a week or two. Imaging scheduling, HSG timing (which must happen in the follicular phase of the cycle), and waiting for results all extend the timeline. A complete workup typically takes two to four months.
When Investigation Finds Nothing
Even after a complete guideline-recommended workup, 50 to 55 percent of women have no identified cause for their recurrent losses. This is called unexplained recurrent pregnancy loss, and it is frustrating—you want a cause to point to, a reason that explains the pattern. The absence of identified cause, however, does not mean absence of reason.
It means the cause falls outside the scope of routine testing. Possible causes of unexplained loss include subtle immune factors, uterine blood flow problems not detected by imaging, undiagnosed infections, or factors we simply do not yet fully understand. There may be reasons; the tests just did not find them. This is not a failing of testing—it reflects the limits of current knowledge.
The good news is that prognosis for unexplained recurrent loss is still favorable. Approximately 75 percent of women with unexplained RPL achieve a successful pregnancy without medical intervention. This means that in the next attempt at pregnancy, most women will carry to term and deliver a healthy baby. The losses were not predictive; they were a run of bad luck.
Some women with unexplained loss are treated with low-dose aspirin or other interventions, though evidence for benefit is weaker than for treated causes like APS. Others move forward with next pregnancy without additional treatment. The decision depends on how many losses you have had, your age, whether you want to intervene, and what your doctor recommends.
Having a diagnosis changes the plan: if APS is found, specific treatment is given; if a translocation is found, options including IVF with genetic testing are discussed; if a structural problem is found, surgery may be offered. With unexplained loss, the plan is usually expectant management—attempting next pregnancy with monitoring and support.
Age, Egg Quality, and Why Outcomes Are Still Favorable
Age affects miscarriage risk at every stage of reproduction. Eggs are present from birth; as a woman ages, eggs age. Older eggs are more prone to errors during division, producing chromosomally abnormal eggs. This is why miscarriage risk climbs with age: at age 20, about 10 percent of pregnancies miscarry; at age 40, about 30 percent do; at age 45, about 50 percent do.
For recurrent loss, age is a risk factor but not a barrier to successful pregnancy. A 45-year-old woman with two losses faces a higher background miscarriage risk than a 30-year-old, but she still has a favorable chance of success on next attempt. Age should inform the urgency of investigation and next attempt, not discourage trying.
Egg freezing or in vitro fertilization with preimplantation genetic testing may be discussed with older women with recurrent loss, particularly if a cause like parental translocation is found. PGT allows selection of chromosomally normal embryos, which substantially improves success. However, even without PGT, older women continue to have successful pregnancies after recurrent loss. Time is still on your side even if multiple losses have occurred.
Two losses, three losses, or more—the losses are not predictive of a permanent problem. Each pregnancy is independent. The next one could be healthy. Women routinely go on to have successful pregnancies after multiple prior losses, sometimes without any intervention beyond expectation and support. Maternal age also affects the intensity and urgency of investigation. A woman age 25 with two losses has more time to investigate and attempt.
A woman age 40 with two losses may choose to move through investigation more quickly or to pursue more aggressive next-pregnancy management. Your age should inform your timeline, but not the fundamental approach or expectation of success.
Choosing Your Healthcare Team and Preparing for Investigation
Most of your initial evaluation may happen with your primary obstetrician-gynecologist, but after two losses—particularly if you are age 35 or older—consulting a reproductive endocrinologist (fertility specialist) or maternal-fetal medicine specialist is often recommended. These specialists have depth in recurrent loss investigation and management. A reproductive endocrinologist is trained in the full evaluation and in assisted reproduction if needed.
A maternal-fetal medicine specialist focuses on high-risk pregnancies and can provide intensive monitoring in a next pregnancy. When you see a specialist, bring documentation of your losses: ultrasound reports showing pregnancy viability and the loss, pathology reports if tissue was examined, and any prior testing results. If you have retained tissue from a loss, ask whether it should be sent for chromosomal testing.
Many women find that tissue testing is not offered unless asked—it is easy to let a loss pass without analysis. Tissue does not remain viable forever, so this decision needs to be made soon after a loss. Discuss whether you want to attempt testing of tissue in a next loss. Some women decide in advance that if another loss occurs, they will seek tissue testing to add data to their picture.
Others find that decision too painful to make in advance and will decide in the moment. Both approaches are valid. What matters is that tissue is not discarded without considering whether you would want it tested. Create a clear summary of your losses: the dates, how far along each was, and any complications. Bring this to appointments.
It helps your doctor see the pattern and informs decisions about which tests to order. If losses have been at different gestational ages, that information guides investigation differently than if all losses have been first-trimester. Be clear about your goals and timeline. Are you eager to attempt another pregnancy quickly? Do you want a complete workup before trying again? Is your interest in understanding the cause, even if it does not change management? Honest communication helps your doctor tailor the plan to you, not to a generic approach.
Moving Forward After Investigation and Next Pregnancy Planning
Once investigation is complete, the plan depends on findings. If a cause is identified—APS, a structural abnormality, or parental translocation—treatment is offered. For APS, aspirin and heparin in next pregnancy offer excellent protection. For structural problems, surgery before next pregnancy improves odds. For parental translocation, options include natural attempt, IVF with PGT, or adoption. If investigation found nothing, the plan is often watchful expectancy: attempt next pregnancy, monitor carefully, and avoid unnecessary intervention.
Support is still important—close follow-up with your doctor, early ultrasound confirmation of viability, and professional or peer support through the anxiety of early pregnancy. Many women find that carrying a pregnancy after loss is emotionally fraught even when success odds are high. Timing next pregnancy involves personal, emotional, and medical considerations. Medically, waiting is not required—you can attempt pregnancy immediately after a loss if you and your doctor agree.
Some women feel they need time to grieve, heal, or resolve questions through investigation. Some want to move forward quickly. Both impulses are valid. Waiting to feel ready is different from medically necessary waiting. Preparation for next pregnancy may include prenatal vitamins with folic acid, smoking cessation if relevant, managing other medical conditions, and reducing preventable infections.
If you have unexplained loss, avoiding unnecessary stress is reasonable, but so is continuing normal life—miscarriage is not caused by stress, and activity restrictions do not prevent loss. Inform your next care provider about your loss history immediately. In early pregnancy, you may get more frequent ultrasounds, earlier confirmations of viability, and closer monitoring. Some practices move you to specialist care once prior losses are known.
Others monitor but do not change routine. Your preference and your doctor's approach guide the care you receive. The arc from loss to investigation to next pregnancy is long. Many women find support invaluable—talking with others who have had recurrent loss, working with a therapist, or connecting with grief resources. The medical facts are hopeful—you likely will carry a healthy pregnancy—but the emotional weight of repeated loss deserves attention and care alongside the clinical plan.
Frequently Asked Questions
How many miscarriages count as recurrent?
Two documented pregnancy losses now prompt investigation, according to current medical guidelines. The older definition of three or more losses is considered outdated for initial evaluation because earlier investigation can identify and treat problems sooner.
Is recurrent miscarriage my fault?
No. The majority of recurrent losses are caused by random chromosomal errors in the embryo, parental chromosome rearrangements, blood-clotting disorders, or structural uterine problems—none of which result from anything you did. Even with unexplained loss, there is no evidence linking it to stress, exercise, diet, or lifestyle choices.
Will I ever have a successful pregnancy after recurrent miscarriage?
Yes. Approximately 75% of women with recurrent pregnancy loss achieve a successful pregnancy without any medical intervention. Even if a cause is identified and treated, outcomes improve substantially.
What is the first test I should have after two losses?
If tissue from a loss is available, chromosomal testing of that tissue should be your first test. It identifies whether losses are random chromosomal errors or point toward other problems like a parental chromosome rearrangement. If tissue is not available, your doctor will likely recommend blood tests for you and your partner to check chromosomes and, conditionally, for blood-clotting disorders.
Does recurrent miscarriage run in families?
A balanced chromosome rearrangement, which accounts for 3–5% of recurrent loss, can run in families. Most causes of recurrent loss, however, are not inherited. Chromosomal errors in embryos are random. Antiphospholipid syndrome is autoimmune, not inherited. Structural uterine problems are usually not hereditary.
How long does the investigation take?
A complete workup typically takes two to four months. Chromosomal testing of tissue can take weeks; parental karyotyping takes one to two weeks; scheduling imaging and waiting for results adds more time. Some tests must be timed to phases of your cycle, which extends the timeline further.
